Dihydroisoferulic Acid 3-O-Glucuronide
|
- $185 - $650
- Product name: Dihydroisoferulic Acid 3-O-Glucuronide
- CAS: 1187945-72-7
- MF: C16H20O10
- MW: 372.32
- EINECS:
- MDL Number:MFCD31562457
- Synonyms:5-(2-Carboxyethyl)-2-Methoxyphenyl β-D-Glucopyranosiduronic Acid;Dihydro Isoferulic Acid 3-O-β-D-Glucuronide;Dihydroisoferulic Acid 3-O-Glucuronide;β-D-Glucopyranosiduronic acid, 5-(2-carboxyethyl)-2-methoxyphenyl;Dihydro Isoferulic Acid-β-O-β-D-Glucuronide;Dihydro Isoferulic Acid 3-O-β-D-Glucuronide
2 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 2.5mg
- ManufacturerMedical Isotopes, Inc.
- Product number50944
- Product descriptionDihydroIsoferulicAcid3-O-β-D-Glucuronide
- Packaging2.5mg
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD448940
- Product descriptionDihydroIsoferulicAcid3-O-β-D-Glucuronide
- Packaging2.5mg
- Price$185
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 50944 | DihydroIsoferulicAcid3-O-β-D-Glucuronide | 2.5mg | $650 | 2021-12-16 | Buy |
| TRC | D448940 | DihydroIsoferulicAcid3-O-β-D-Glucuronide | 2.5mg | $185 | 2021-12-16 | Buy |
Properties
Melting point :>128°C (dec.)
Boiling point :667.6±55.0 °C(Predicted)
Density :1.563±0.06 g/cm3(Predicted)
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :Methanol (Slightly), Water (Slightly, Heated, Sonicated)
form :Solid
pka :2.79±0.70(Predicted)
color :White to Pale Brown
Stability :Hygroscopic
Boiling point :667.6±55.0 °C(Predicted)
Density :1.563±0.06 g/cm3(Predicted)
storage temp. :Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility :Methanol (Slightly), Water (Slightly, Heated, Sonicated)
form :Solid
pka :2.79±0.70(Predicted)
color :White to Pale Brown
Stability :Hygroscopic
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|